India's Dabur Pharma got the FDA's tentative OK to sell a generic version of Camptosar, Pfizer's colon cancer treatment. Report [1]
India's Dabur Pharma got the FDA's tentative OK to sell a generic version of Camptosar, Pfizer's colon cancer treatment. Report [1]
Links:
[1] http://www.forbes.com/markets/feeds/afx/2007/10/30/afx4276679.html